Stocktoria
RadNet, Inc. RDNT
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2001-12-12
RadNet, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 3.0% | 5.7% | 6.1% | 3.2% | 6.3% |
| Net margin | -0.9% | 0.2% | 0.2% | 0.7% | 1.9% |
| Return on assets | -0.5% | 0.1% | 0.1% | 0.4% | 1.2% |
| Return on equity | -1.4% | 0.2% | 0.4% | 2.2% | 7.1% |
| Debt / equity | 0.80× | 0.90× | 1.02× | 1.73× | 2.18× |
| Current ratio | 1.76 | 2.12 | 1.32 | 0.79 | 0.87 |
| Revenue growth | 11.5% | 13.2% | 13.0% | 8.7% | 22.7% |
Source: SEC EDGAR filings · CIK 0000790526 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.